Nature-inspired nanocarriers for improving drug therapy of atherosclerosis.

Authors:
Ji W; Zhang Y; Deng Y; Li C; Kankala RK and 1 more

Journal:
Regen Biomater

Publication Year: 2023

DOI:
10.1093/rb/rbad069

PMCID:
PMC10460486

PMID:
37641591

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Regen Biomater

Abbreviation: Regen Biomater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Materials Science, Biomaterials

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
3D printing sequentially strengthening high-strength natural polymer hydrogel bilayer scaffold for …
Nie X; Tang Y; Wu T and 8 more (2024) - Transparency Score: 3/6
Advances in functional coatings on biliary stents.
Yang K; Sun W; Cui L and 3 more (2024) - Transparency Score: 3/6
Anisotropic microtopography surface of chitosan scaffold regulating skin precursor-derived Schwann …
Cong M; Wu X; Zhu L and 4 more (2024) - Transparency Score: 3/6
Antioxidant and anti-inflammatory injectable hydrogel microspheres for <i>in situ</i> treatment of …
Han Q; Bai L; Qian Y and 6 more (2024) - Transparency Score: 3/6
Application of metal-organic frameworks-based functional composite scaffolds in tissue engineering.
Yao X; Chen X; Sun Y and 3 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest statement. The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This study was financially supported by the National Natural Science Foundation of China (NSFC 32071323 and 32271410), Program for Innovative Research Team in Science and Technology in Fujian Province University, Scientific Research Funds of Huaqiao University (22BS125). Conflicts of interest statement. The authors declare that they have no conflict of interest."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025